US 11352395
Anticancer peptides
granted A61KA61K38/00A61K47/51
Quick answer
US patent 11352395 (Anticancer peptides) held by IDP DISCOVERY PHARMA, S.L. expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- IDP DISCOVERY PHARMA, S.L.
- Grant date
- Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/00, A61K47/51, A61P, A61P35/00